(Hypertension. 2000;36:604.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
Angiotensin II–Induced Hypertension
Contribution of Ras GTPase/Mitogen-Activated Protein Kinase and Cytochrome P450 Metabolites
From the Departments of Pharmacology (M.M.M., N.A.K., Z.K, A.E.S., J.-H.P., A.E., K.U.M.) and Pathology (L.G.), University of Tennessee, Memphis; and Division of Biomedical Sciences (I.F.B.), Southern College of Optometry, Memphis, Tenn.
Correspondence to Dr Kafait U. Malik, Department of Pharmacology, College of Medicine, The University of Tennessee, 874 Union Ave, Memphis, TN 38163. E-mail kmalik{at}utmem1.utmem.edu
Abstract—We reported that norepinephrine and angiotensin II (Ang II) activate the Ras/mitogen-activated protein (MAP) kinase pathway primarily through the generation of cytochrome P450 (CYP450) metabolites. The purpose of the present study was to determine the contribution of Ras and CYP450 to Ang II–dependent hypertension in rats. Infusion of Ang II (350 ng/min for 6 days) elevated mean arterial blood pressure (MABP) (171±3 mm Hg for Ang II versus 94±5 for vehicle group, P<0.05). Ras is activated on farnesylation by farnesyl protein transferase (FPT). When Ang II was infused in combination with FPT inhibitor FPT III (232 ng/min) or BMS-191563 (578 ng/min), the development of hypertension was attenuated (171±3 mm Hg for Ang II plus vehicle versus 134±5 mm Hg for Ang II plus FPT III and 116±6 mm Hg for Ang II plus BMS-191563, P<0.05). Treatment with the MAP kinase kinase inhibitor PD-98059 (5 mg SC) reduced MABP. The CYP450 inhibitor aminobenzotriazole (50 mg/kg) also diminished the development of Ang II–induced hypertension to 113±8 mm Hg. The activities of Ras, MAP kinase, and CYP450 measured in the kidney were elevated in hypertensive animals. The infusion of FPT III, BMS-191563, or aminobenzotriazole reduced the elevation in Ras and MAP kinase activity. Morphological studies of the kidney showed that FPT III treatment ameliorated the arterial injury, vascular lesions, fibrinoid necrosis, focal hemorrhage, and hypertrophy of muscle walls observed in hypertensive animals. These data suggest that the activation of Ras and CYP450 contributes to the development of Ang II–dependent hypertension and associated vascular pathology.
Key Words: angiotensin II • Ras • kinases • hypertension, experimental • cytochrome P450 • kidney
This article has been cited by other articles:
 |
|
 |
|
  S.-G. Wei, Y. Yu, Z.-H. Zhang, R. M. Weiss, and R. B. Felder Angiotensin II-Triggered p44/42 Mitogen-Activated Protein Kinase Mediates Sympathetic Excitation in Heart Failure Rats Hypertension, August 1, 2008; 52(2): 342 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Liang, H. E. Ives, C.-M. Yang, and Y.-H. Ma 20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor- J. Lipid Res., January 1, 2008; 49(1): 66 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Escano Jr., L. B. Keever, A. A. Gutweiler, and B. T. Andresen Angiotensin II Activates Extracellular Signal-Regulated Kinase Independently of Receptor Tyrosine Kinases in Renal Smooth Muscle Cells: Implications for Blood Pressure Regulation J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 34 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ishizuka, J. Cheng, H. Singh, M. D. Vitto, V. L. Manthati, J. R. Falck, and M. Laniado-Schwartzman 20-Hydroxyeicosatetraenoic Acid Stimulates Nuclear Factor-{kappa}B Activation and the Production of Inflammatory Cytokines in Human Endothelial Cells J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 103 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Singh, J. Cheng, H. Deng, R. Kemp, T. Ishizuka, A. Nasjletti, and M. L. Schwartzman Vascular Cytochrome P450 4A Expression and 20-Hydroxyeicosatetraenoic Acid Synthesis Contribute to Endothelial Dysfunction in Androgen-Induced Hypertension Hypertension, July 1, 2007; 50(1): 123 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Wang, H. Singh, F. Zhang, T. Ishizuka, H. Deng, R. Kemp, M. S. Wolin, T. H. Hintze, N. G. Abraham, A. Nasjletti, et al. Endothelial Dysfunction and Hypertension in Rats Transduced With CYP4A2 Adenovirus Circ. Res., April 14, 2006; 98(7): 962 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takeuchi, M. Renic, Q. C. Bohman, D. R. Harder, N. Miyata, and R. J. Roman Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2203 - H2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Yaghini, C. Zhang, J.-H. Parmentier, A. M. Estes, N. Jafari, S. A. Schaefer, and K. U. Malik Contribution of Arachidonic Acid Metabolites Derived Via Cytochrome P4504A to Angiotensin II-Induced Neointimal Growth Hypertension, June 1, 2005; 45(6): 1182 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Andresen, K. Shome, E. K. Jackson, and G. G. Romero AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity Am J Physiol Renal Physiol, April 1, 2005; 288(4): F763 - F770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Isenovic, D. B. Jacobs, M. H. Kedees, Q. Sha, N. Milivojevic, K. Kawakami, G. Gick, and J. R. Sowers Angiotensin II Regulation of the Na+ Pump Involves the Phosphatidylinositol-3 Kinase and p42/44 Mitogen-Activated Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells Endocrinology, March 1, 2004; 145(3): 1151 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Kaduce, X. Fang, S. D. Harmon, C. L. Oltman, K. C. Dellsperger, L. M. Teesch, V. R. Gopal, J. R. Falck, W. B. Campbell, N. L. Weintraub, et al. 20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells J. Biol. Chem., January 23, 2004; 279(4): 2648 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-X. Zhang, S. Kimura, A. Nishiyama, T. Shokoji, M. Rahman, and Y. Abe ROS During the Acute Phase of Ang II Hypertension Participates in Cardiovascular MAPK Activation But Not Vasoconstriction Hypertension, January 1, 2004; 43(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Hoagland, A. K. Flasch, and R. J. Roman Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats Hypertension, October 1, 2003; 42(4): 669 - 673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Amaral, K. G. Maier, D. N. Schippers, R. J. Roman, and A. S. Greene CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1528 - H1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Andresen, J. J. Linnoila, E. K. Jackson, and G. G. Romero Role of EGFR Transactivation in Angiotensin II Signaling to Extracellular Regulated Kinase in Preglomerular Smooth Muscle Cells Hypertension, March 1, 2003; 41(3): 781 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Massett, Z. Ungvari, A. Csiszar, G. Kaley, and A. Koller Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2282 - H2287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kagiyama, S. Eguchi, G. D. Frank, T. Inagami, Y. C. Zhang, and M. I. Phillips Angiotensin II-Induced Cardiac Hypertrophy and Hypertension Are Attenuated by Epidermal Growth Factor Receptor Antisense Circulation, August 20, 2002; 106(8): 909 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Alonso-Galicia, K. G. Maier, A. S. Greene, A. W. Cowley Jr., and R. J. Roman Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R60 - R68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamakawa, S.-i. Tanaka, Y. Yamakawa, J. Kamei, K. Numaguchi, E. D. Motley, T. Inagami, and S. Eguchi Lysophosphatidylcholine Activates Extracellular Signal-Regulated Kinases 1/2 Through Reactive Oxygen Species in Rat Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 752 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Muthalif, N. A. Karzoun, I. F. Benter, L. Gaber, F. Ljuca, M. R. Uddin, Z. Khandekar, A. Estes, and K. U. Malik Functional Significance of Activation of Calcium/Calmodulin-Dependent Protein Kinase II in Angiotensin II-Induced Vascular Hyperplasia and Hypertension Hypertension, February 1, 2002; 39(2): 704 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Hoagland, K. G. Maier, C. Moreno, M. Yu, and R. J. Roman Cytochrome P450 metabolites of arachidonic acid: novel regulators of renal function Nephrol. Dial. Transplant., December 1, 2001; 16(12): 2283 - 2285. [Full Text] [PDF]
|
|
|
|
|
|
M. Seyedabadi, A. K. Goodchild, and P. M. Pilowsky Differential Role of Kinases in Brain Stem of Hypertensive and Normotensive Rats Hypertension, November 1, 2001; 38(5): 1087 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Parmentier, M. M. Muthalif, A. T. Nishimoto, and K. U. Malik 20-Hydroxyeicosatetraenoic Acid Mediates Angiotensin II-Induced Phospholipase D Activation in Vascular Smooth Muscle Cells Hypertension, February 1, 2001; 37(2): 623 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Parmentier, M. M. Muthalif, A. E. Saeed, and K. U. Malik Phospholipase D Activation by Norepinephrine Is Mediated by 12(S)-, 15(S)-, and 20-Hydroxyeicosatetraenoic Acids Generated by Stimulation of Cytosolic Phospholipase A2. TYROSINE PHOSPHORYLATION OF PHOSPHOLIPASE D2 IN RESPONSE TO NOREPINEPHRINE J. Biol. Chem., May 4, 2001; 276(19): 15704 - 15711. [Abstract] [Full Text] [PDF]
|
|